CIK 0001388320
- Non-accelerated filer
- Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880378336
- Phone
- +1 646-677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-12 | Ludwig Dale L. Chief Science & Tech. Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-07-12 | Ludwig Dale L. Chief Scientific Officer | Grant or award · Options to purchase common stock | +400,000 | $0.23 | $93K | 400,000 |
| 2018-11-19 | Ludwig Dale L. Chief Scientific Officer | Purchase | +10,000 | $0.45 | $4K | 10,000 |
Page 1 of 1 · 3 trades